Custom Search
FDA Information
Methylprednisolone was originally approved by the FDA in 1957.
NOTE: methylprednisolone is FDA approved for the palliative treatment of leukemia or non-Hodgkin’s lymphoma in adults, and acute leukemia for childhood. It is also indicated for the treatment of hypercalcemia (high levels of calcium in the blood) associated with cancer.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?